Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0834 per EA under NDC 76282067001. Its NADAC has been published 323 times since Jun 17, 2020.
FDA first approved this application on Jun 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282067001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077900FDA Approved
6/18/2008
TE Code
AB
On Market Since
6/18/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 323 times since Jun 17, 2020, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0834 per EA |
|---|---|
| All-time high | $0.1631 (Dec 16, 2020) |
| All-time low | $0.0626 (Jul 17, 2024) |
| 52-week high | $0.0989 |
| 52-week low | $0.0778 |
| Median price | $0.0974 |
| Average price | $0.1012 |
| Largest weekly change | +82.1% (Mar 20, 2024) |
| Weeks tracked | 323 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0834 per EA (NDC 76282067001), effective Aug 19, 2026.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 23.1%. It has been tracked across 323 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Jun 17, 2020, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.0626 (Jul 17, 2024) to a high of $0.1631 (Dec 16, 2020), with a median of $0.0974 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RAMIPRIL 1.25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 76282067001) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.